NEW YORK (GenomeWeb News) – Abraxis BioScience has awarded the John Wayne Cancer Institute at Saint John's Health Center in Santa Monica, Calif., a $1 million grant to search for genes and proteins that can serve as biomarkers for solid-tumor cancers.

The funding was awarded to John Wayne's Department of Molecular Oncology, directed by Dave Hoon. The research is designed to help develop new biomarker-specific blood tests for detecting cancer, the cancer institute said in a statement Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.